RxDoctor Payments Data

Terry Miller, MD

Family Medicine · Freeport, ILNPI 1164498366

Payments from drug & device makers

$7,285in general payments, 2019–2025

Across 471 payments — averaging $15.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$850
  • GSK$764
  • Novo Nordisk$482
  • Johnson & Johnson$455
  • Lilly USA, LLC$423
  • Boehringer Ingelheim$419
  • plus $4K from 35 others

What the payments were for

  • Food & beverage$7,275100%
  • Education$100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,285 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$154,302
Medicare patients
387
Services billed
6,732

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban254$185,958
EliquisApixaban197$144,379
JanuviaSitagliptin Phosphate132$78,018
OzempicSemaglutide44$55,816
MounjaroTirzepatide49$50,866
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog148$44,973
Breo ElliptaFluticasone/Vilanterol84$44,885
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog32$25,398
FarxigaDapagliflozin Propanediol26$23,230
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$21,747
JardianceEmpagliflozin17$20,613
Aripiprazole161$19,094
TrulicityDulaglutide13$12,723
CreonLipase/Protease/Amylase13$11,499
LinzessLinaclotide17$10,235

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$455$185,958254 claims
PfizerEliquis$850$144,379197 claims
MerckJanuvia$119$78,018132 claims
GSKBreo Ellipta, Trelegy Ellipta$764$66,632106 claims
Lilly USA, LLCMounjaro, Trulicity$423$63,59062 claims
Novo NordiskOzempic$482$55,81644 claims
Boehringer IngelheimJardiance, Jentadueto$419$26,75328 claims
AbbVieCreon, Linzess, Lumigan$311$26,66547 claims
AstraZenecaFarxiga$394$23,23026 claims
Sumitomo Pharma America, Inc.Gemtesa$64$7,39020 claims
Astellas Pharma US IncMyrbetriq$112$7,10917 claims
UCB, Inc.Vimpat$36$6,88412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Freeport

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →